Come True Biomedical Inc. announced earnings results for the third quarter and nine months ended September 30, 2018. For the third quarter, the company announced sales was TWD 21.273 million compared to TWD 40.363 million a year ago. Net loss was TWD 9.106 million compared to TWD 18.888 million a year ago. Basic loss per share was TWD 0.29 compared to TWD 0.59 a year ago.

For the nine months, sales was TWD 74.770 million compared to TWD 129.420 million a year ago. Net loss was TWD 49.511 million compared to TWD 51.030 million a year ago. Basic loss per share was TWD 1.56 compared to TWD 1.61 a year ago.

For the quarter, the company reported impairment loss of TWD 24.00 million.